Davies Collison Cave | Australia | 6 Mar 2023
On 2 March 2023, the Australian Competition and Consumer Commission (ACCC) released its findings of its internet sweep of environmental claims as…
Davies Collison Cave | Australia, New Zealand | 5 Mar 2023
A recent New Zealand trade mark opposition decision indicates just how difficult it is to lodge evidence “out of time”, demonstrating a distinction…
Davies Collison Cave | Australia, Singapore | 3 Mar 2023
Sufficiency of disclosure is a cornerstone of patent law and is part of a “patent bargain” for providing a limited-term monopoly over an invention…
Davies Collison Cave | European Union | 27 Feb 2023
On 1 June 2023, a new Unified Patent Court (UPC) and Unitary Patent (UP) will come into effect, leaving European patent holders with a number of…
Davies Collison Cave | Australia | 24 Feb 2023
A generational energy transition is currently underway on a global scale, promising to be the dawn of a new industrial age. Worldwide investment in…
Davies Collison Cave | Hong Kong | 9 Feb 2023
As a Special Administration Region (SAR) of China, Hong Kong still retains much of the basic common law and legal system that was established under…
Davies Collison Cave | Australia | 6 Feb 2023
In a decision released on 3 February 2023, the Australian Therapeutic Goods Administration (TGA) have agreed to amend the Poisons Standard to include…
Davies Collison Cave | Singapore | 31 Jan 2023
Chen & Partners (S) Pte Ltd v Soon Ailing [2023] SGIPOS 3 (“Ailing v Chen”) concerned revocation of a design registered to Chen & Partners (S) Pte…
Davies Collison Cave | China, Hong Kong | 15 Jan 2023
The Chinese and Hong Kong IP offices (CNIPA and HKIPD) have announced a pilot project for prioritised examination of Mainland Chinese invention…
Davies Collison Cave | Hong Kong | 10 Jan 2023
As from 1 February 2023 Hong Kong will ban cannabidiol (CBD), including all Products Containing CBD. CBD will be added to the Dangerous Drugs…